Bielsa S, Panadés M J, Egido R, Rue M, Salud A, Matías-Guiu X, Rodríguez-Panadero F, Porcel J M
Servicio de Medicina Interna, IRBLLEIDA, Lleida, Spain.
An Med Interna. 2008 Apr;25(4):173-7. doi: 10.4321/s0212-71992008000400005.
To assess the usefulness of repeat cytological examination of pleural fluid (PF) for diagnosing malignancy as well as the influence of time length between analyses, effusion's size and pleural fluid biochemistries on the diagnostic yield of cytology.
Retrospective analysis of 1,427 patients with pleural effusion (PE), including 466 patients with malignant PE. In this latter group, the time length between cytological analysis, the size of the PE, and the biochemical characteristics of PF were recorded.
The first cytological analysis had a sensitivity of 48.5%. If this was negative, a second PF specimen was diagnostic in 28.6% of cases, whereas submission of a third PF specimen allowed 10.3% of additional diagnosis. The incidence of positive results depended on the primary tumor (e.g. 66.5% in adenocarcinomas, 30.8% in mesotheliomas), but neither on the time length between cytological analyses nor on the effusion's size. A multivariate analysis showed that a PF to serum glucose ratio </= 0.75 was associated with a higher diagnostic yield of cytology (74 vs. 47%, p < 0.001).
At least a second PF specimen should be submitted immediately for cytologic analyis in all PE of unknown cause, when the first analysis is not contributory. To delay this second analysis does not increase diagnostic yield. The percentage of cases in which cytologic study of the PF established the diagnosis of malignant PE depends on the tumor type and on certain PF biochemical characteristics such as the PF to serum glucose ratio.
评估重复进行胸腔积液(PF)细胞学检查对恶性肿瘤诊断的实用性,以及分析间隔时间、积液大小和胸腔积液生物化学指标对细胞学诊断率的影响。
对1427例胸腔积液(PE)患者进行回顾性分析,其中包括466例恶性PE患者。记录后一组患者的细胞学分析间隔时间、PE大小和PF的生化特征。
首次细胞学分析的敏感性为48.5%。若首次分析结果为阴性,第二次PF标本诊断出恶性肿瘤的病例占28.6%,而提交第三次PF标本又能额外诊断出10.3%的病例。阳性结果的发生率取决于原发肿瘤(如腺癌为66.5%,间皮瘤为30.8%),但既不取决于细胞学分析的间隔时间,也不取决于积液大小。多因素分析显示,PF与血清葡萄糖比值≤0.75与更高的细胞学诊断率相关(74%对47%,p<0.001)。
对于所有病因不明的PE患者,若首次细胞学分析无诊断价值,应立即至少提交第二次PF标本进行细胞学分析。延迟第二次分析并不会提高诊断率。通过PF细胞学检查确诊恶性PE的病例百分比取决于肿瘤类型以及某些PF生化特征,如PF与血清葡萄糖比值。